Alcon Laboratories Inc., Fisher deal

ACL and FSH's Dharmacon Inc. subsidiary (Lafayette, Colo.) partnered to develop RNAi therapeutics for ophthalmic diseases. The deal combines Dharmacon's RNAi technologies with ACL's ophthalmic diseas...